| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Grace Therapeutics, Inc. | VP Program Management | Stock Option (Right to Buy) | 30K | 14 Apr 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| GRCE | Grace Therapeutics, Inc. | 14 Apr 2025 | 1 | $0 | 4 | VP Program Management | 16 Apr 2025, 20:58 |
| ACST | Acasti Pharma Inc. | 06 May 2024 | 1 | $0 | 4/A | VP Program Management | 10 May 2024, 16:07 |
| ACST | Acasti Pharma Inc. | 06 May 2024 | 1 | $0 | 4 | VP Clinical Operations | 08 May 2024, 19:19 |
| ACST | Acasti Pharma Inc. | 14 Jul 2023 | 1 | $0 | 4 | VP Program Management | 18 Jul 2023, 16:28 |
| ACST | Acasti Pharma Inc. | 08 May 2023 | 0 | $0 | 3 | VP Program Management | 18 May 2023, 15:57 |